Drug Checking as Market Surveillance

In the shadowed corners of unregulated drug markets, the contents of a small bag are a mystery until it is too late. For decades, public health efforts have focused on a simple idea: if a person who uses drugs could know exactly what is inside a bag before they take it, they could make safer choices. This concept, known as drug checking, has been promoted as a vital tool to prevent overdoses. The hope is that by revealing the chemical makeup of a substance, individuals can avoid dangerous surprises, such as a bag of heroin that has been mixed with a much stronger synthetic opioid. However, recent observations suggest that this individual-focused approach may be too narrow for the chaotic reality of street-level markets. The drugs sold on the street are not static products; they are fluid, changing rapidly in response to supply, demand, and competition. Understanding how these markets actually work requires looking beyond the single person holding a test sample and examining the entire flow of information that moves between buyers, sellers, and the products themselves.

A team of researchers from St. Ann's Corner of Harm Reduction in the South Bronx, New York, set out to test a different way of thinking about this problem. Instead of waiting for people to bring in samples one by one, they treated drug checking as a form of active market surveillance. Over the course of their study, they analyzed approximately 500 samples using a method called Fourier Transform Infrared spectroscopy, which identifies substances by how they absorb infrared light. This allowed them to map the chemical landscape of the local drug supply with high precision. They found a complex mix of substances, including fentanyl, heroin, benzodiazepines, and various fillers like lactose and caffeine, as well as newer, more dangerous additives like medetomidine. But the most significant discovery was not just what was in the bags, but how quickly the contents changed. By repeatedly testing bags sold in the same neighborhood, the researchers observed that the chemical composition of a specific product could shift dramatically over a very short period.

The researchers focused their attention on "stamped" bags, which are small packets of drugs marked with a specific name or symbol. Historically, these stamps acted as brands, telling buyers which organization made the product. In the past, a stamp like "No Joke" or "Tango and Cash" might have guaranteed a consistent source and a predictable effect. Today, however, the meaning of these stamps has evolved. The study found that while a stamp no longer guarantees a specific organization or a consistent level of potency, it still serves as a recognizable identity for the product. A bag marked "G.O.A.T." or "Monster High" might look the same from week to week, but the researchers discovered that the chemicals inside could change completely. One batch might be mostly fentanyl, while the next could be dominated by a different substance entirely. This rapid shifting means that a stamp is no longer a reliable promise of what is inside, but it remains a crucial handle for communicating information.

The study highlights three major flaws in the traditional way drug checking is done. First, there is often a dangerous delay between when a sample is tested and when the warning reaches the community. If a person brings a bag to a testing site and waits days for the results, the information arrives too late to prevent an overdose that might have happened that same afternoon. Second, the results are usually shared only with the person who brought the sample. This keeps the information isolated, even though the same batch of drugs might be circulating widely among many other people. Third, these programs rarely talk to the people selling the drugs. The researchers found that this is a missed opportunity. Street-level dealers are part of the information network, and they react to what they hear. In one instance, a dealer complained that customers were avoiding his product because a flyer from the harm reduction program said it contained unwanted substances. In another case, a dealer used the test results to brag that his product was "cleaner" than his competitors'.

The researchers argue that drug checking should be viewed not just as a service for individuals, but as a way to monitor and influence the entire market. By testing multiple products over time, they could see patterns that a single test would miss. They found that when information about a specific stamped product was shared widely—through flyers distributed to both buyers and sellers—it changed behavior. People began asking for specific bags that were known to be safer or avoiding those known to be dangerous. Dealers, in turn, began to adjust their sales tactics based on this chemical intelligence. This suggests that the value of drug checking extends far beyond the moment a person decides whether to use a specific bag. It alters the information environment in which the market operates.

The study concludes that in a market where people may need drugs to avoid withdrawal and have little control over what they buy, the goal of drug checking should shift. It is not enough to simply tell one person that their bag is dangerous. The intervention must be fast enough to catch hazards before they spread, and it must be broad enough to reach everyone who might encounter the product. The researchers suggest that harm reduction programs might even encourage dealers to use consistent stamps or identifiers. While this sounds counterintuitive, as branding is usually associated with selling drugs, a consistent stamp allows health workers to attach chemical warnings to a recognizable product. This turns the stamp into a tool for public safety, allowing information to travel with the product itself. By treating drug checking as a form of market surveillance, the study suggests we can better understand and respond to the rapidly changing dangers of the unregulated drug supply.